SynthesisMayo Clinic proceedings2009
The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research.
Synthesis in Mayo Clinic proceedings, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Migraine and the risk of dementia: a meta-analysis and systematic review.Aging clinical and experimental research · 2022Pooled it
- Preventive pharmacologic treatments for episodic migraine in adults.Journal of general internal medicine · 2013Pooled it
- Effectiveness of Combined Copying Skills Training and Pharmacological Therapy for Patients with Migraine.Global journal of health science · 2015Trial
- A proactive approach to migraine in primary care: a pragmatic randomized controlled trial.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2012Trial
- Spectral Composition of Ambient White Light Modulates Photophobia and Headache Intensity During Migraine Attacks.Neurology and therapy · 2026Article
- Repetitive Transcranial Magnetic Stimulation in Migraine: Clinical Outcomes and Neurobiological Mechanisms-A Systematic Review.Neurology international · 2026Review
- Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME (US) study.Headache · 2026Observational
- Unveiling the Public Economic Burden of Migraine in Argentina.Journal of health economics and outcomes research · 2025Article
- Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life: Results of the OVERCOME (US) StudyNeurology · 2024Observational
- Independent causal effect of migraines on Alzheimer's disease risk: a multivariate Mendelian randomization study.Frontiers in neurology · 2024Article
- Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process.Cephalalgia : an international journal of headache · 2022Review
- Epidemiology and treatment utilization for Canadian patients with migraine: a literature review.The Journal of international medical research · 2022Review
- The Impact of Migraine Disease on Work Productivity and Quality of Life Among the Adults in Riyadh, Saudi Arabia.Cureus · 2022Article
- Eptinezumab for migraine prevention in patients 50 years or older.Acta neurologica Scandinavica · 2022Article
- Managing of Migraine in the Workplaces: Knowledge, Attitudes and Practices of Italian Occupational Physicians.Medicina (Kaunas, Lithuania) · 2022Article
- Migraine: Calcium Channels and Glia.International journal of molecular sciences · 2021Review
- The Economic Burden of Lost Productivity due to Presenteeism Caused by Health Conditions Among Workers in Japan.Journal of occupational and environmental medicine · 2020Article
- Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway.The journal of headache and pain · 2020Article
- Cortical spreading depolarisation-induced facial hyperalgesia, photophobia and hypomotility are ameliorated by sumatriptan and olcegepant.Scientific reports · 2020Article
- United States Patients' Perspective of Living With Migraine: Country-Specific Results From the Global "My Migraine Voice" Survey.Headache · 2020Article
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Evidence suggests that migraine is associated with decreased productivity. This article describes the results of a systematic literature review of peer-reviewed publications that measured the impact of migraine on workplace productivity in the United States and provides recommendations for future research. A MEDLINE search was conducted from January 1, 1990 to July 31, 2008. Articles were included if the results were from a prospective or retrospective study that reported work-specific productivity outcomes in adults with migraine in the United States. Twenty-six studies were included. Nine studies found that diagnosed and/or undiagnosed migraine had a negative impact on worker productivity. Although one migraine prophylactic study found a statistically significant improvement in worker productivity for topiramate-treated patients, another found an insignificant difference in lisinopril-treated patients. Fifteen studies compared the impact of triptan therapy with a control group. The control groups in these studies differed with regard to recall periods, time to follow-up, and types of questionnaires used. Almost all studies found that triptan therapy was associated with a statistically significant improvement in loss in worker productivity vs the control group. Health care professionals can reduce the impact of migraine on worker productivity with appropriate therapy. Researchers should collect presenteeism and absenteeism data, report results in units of time, use a validated instrument, carefully consider recall periods, and report worker productivity separately. In addition, patients with undiagnosed migraine should be included in disease burden studies. When evaluating effects of treatment on productivity, researchers should target well-controlled, double-blind studies and conduct productivity research for new treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.